Categories: CancerHealthcareNews

Inovalon Announces Converged Outreach

The Industry’s Only SaaS Solution for the Coordination of Multiple Concurrent Patient Engagement Initiatives to Optimize Impact and Efficiency

BOWIE, Md., March 06, 2023 (GLOBE NEWSWIRE) — Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today launched Converged Outreach. This new cloud-based SaaS product is a patient outreach orchestration solution that empowers healthcare organizations to coordinate the analytically-derived patient intervention programs of multiple concurrent initiatives to achieve optimal engagement, impact, and efficiency.

Traditional approaches by health plans and other value-based and outcomes-based organizations often have multiple patient engagement initiatives running simultaneously, such as quality improvement, risk score accuracy improvement, smoking cessation, cancer screening, medication adherence, vaccination management, and others. This frequently results in discordant outreach efforts that confuse patients, drive up costs, and add unnecessary friction to both the patient and their providers.

Inovalon’s new cloud-based Converged Outreach SaaS solution enables healthcare organizations to customize integrated, patient-specific intervention programs and coordinate outreach in one efficient solution. Utilizing predictive analytics informed by the data of billions of medical events, Converged Outreach leverages sophisticated algorithms focused on key elements such as patient compliance likelihood, total impact opportunity, and operational workflow optimization. Tracking and modifying programs at the patient level in response to past patient engagements, historical intervention performance results, and resource availability are further differentiators of the solution. The resulting coordinated outreach plan is available to the customer in real-time for provision to their existing resources or a growing ecosystem of third-party healthcare services vendors for the outreach plan’s coordinated intervention plan to be undertaken across the identified patients.

“Inovalon believes in personalized care, and in the power of data to drive the right action at the right time,” said Craig Savage, President and General Manager of Inovalon’s Payer business. “With Converged Outreach, customers have a powerful solution at their fingertips to coordinate programs that otherwise have operated in separate silos, now confidently targeting the right coordinated interventions to the right patient at the right time, driving significant improvements to quality of care, economic outcomes, and clinical performance.”

Converged Outreach is fully interoperable with Inovalon’s cloud-based Converged solution suite, a set of integrated, pure SaaS offerings that simplify implementation, shorten the time to program impact, and avoid the need and cost of additional disparate data integrations, data security auditing processes, vendor management, and operational reporting.

For more information on Converged Outreach, visit inovalon.com/products/payer-cloud/outreach/.

About Inovalon

Inovalon is a leading provider of cloud-based software solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics to enable improved clinical outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by nearly 20,000 customers and are informed by the primary source data of more than 72 billion medical events across one million physicians, 627,000 clinical settings, and 361 million unique patients. For more information, visit www.inovalon.com/.

Contact:

Whitney Swistock
Sr. Manager, Communications, Inovalon
Whitney.Swistock@inovalon.com

Staff

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

11 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

14 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

14 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

14 hours ago